Section 7.1 Laboratory

Laboratory Report #22

Date

Collection Date: July 11, 2022
Report Date: July 12, 2022

Laboratory

Labcorp

Ordering Physician

Dr. Rihab Kheir

Report Type

Inflammation Monitoring Evaluation

Laboratory testing included:

Erythrocyte Sedimentation Rate (ESR)
C-Reactive Protein (CRP)

Original Report

PDF: Labcorp – July 11, 2022

One-Page Summary

Purpose of Testing

This laboratory evaluation was performed during routine rheumatology follow-up to monitor for recurrence of systemic inflammation after the severe inflammatory illness of 2021. The study focused on the two principal inflammatory markers—ESR and CRP—to determine whether inflammatory remission had been maintained. The results continue to support sustained recovery.

Major Findings

Erythrocyte Sedimentation Rate (ESR)

Result

13 mm/hr

Reference Range:

0–30 mm/hr

Interpretation

The ESR remained within the normal reference range.

Trend:

October 2021 (Peak): 71 mm/hr
December 2021: 15 mm/hr
January 2022: 6 mm/hr
February 2022: 13 mm/hr
March 2022: 16 mm/hr
April 2022: 8 mm/hr
June 2022: 4 mm/hr
July 2022: 13 mm/hr

Although the ESR increased compared with the June value, it remained well within the normal range and does not indicate a recurrence of the severe inflammatory process experienced in 2021. Minor fluctuations of this magnitude are common and should be interpreted within the overall trend.

C-Reactive Protein (CRP)

Result

6 mg/L

Reference Range:

0–10 mg/L

Interpretation

CRP remained within the normal laboratory range.

Trend:

October 2021 (Peak): 32 mg/L
December 2021: 2 mg/L
January 2022: 4 mg/L
February 2022: 1 mg/L
March 2022: 3 mg/L
April 2022: 2 mg/L
June 2022: 2 mg/L
July 2022: 6 mg/L

Although CRP increased from the previous month, it remained below the upper limit of normal. This isolated increase is not, by itself, evidence of recurrent systemic inflammatory disease.

Overall Interpretation

This focused laboratory evaluation demonstrates continued control of systemic inflammation. Both ESR and CRP remained within their respective reference ranges despite modest increases from the previous month. There is no laboratory evidence in this report of a return to the inflammatory state documented during late 2021. Continued monitoring remained appropriate given your recent medical history, but the overall findings support ongoing remission.

Longitudinal Significance

This report contributes to:

ESR Trend Table
CRP Trend Table
Systemic Inflammatory Illness Timeline
Rheumatology Consultation Summary
Medical History Timeline

It documents continued inflammatory stability approximately nine months after the peak of the inflammatory illness.

Clinical Importance

⭐⭐⭐⭐ Continued Remission

This report confirms that the inflammatory illness remained under good control. While ESR and CRP rose modestly compared with June 2022, both values stayed within normal limits and did not approach the markedly abnormal levels observed during the active phase of illness.

Key Changes Since Previous Report

Compared with June 6, 2022:

ESR increased from 4 → 13 mm/hr, remaining within the normal range.
CRP increased from 2 → 6 mg/L, remaining within the normal range.
No laboratory evidence of recurrent systemic inflammation.
Continued objective evidence of sustained remission.

Related Reports

August 31, 2021 – Initial Systemic Inflammatory Evaluation
September 7, 2021 – Inflammation Monitoring Evaluation
October 13, 2021 – Peak Systemic Inflammatory Illness Evaluation
December 15, 2021 – Recovery Evaluation
January 12, 2022 – Continued Recovery Evaluation
February 9, 2022 – Autoimmune Evaluation
March 7, 2022 – Sjögren’s Evaluation
April 12, 2022 – Recovery Monitoring Evaluation
June 6, 2022 – Inflammation Monitoring Evaluation
ESR Trend Table
CRP Trend Table
Rheumatology Consultation Summary
Medical History Timeline

Navigation

Previous Report: June 6, 2022 – Inflammation Monitoring Evaluation
Next Report: Subsequent 2022 Laboratory Evaluation
Return to Laboratory Library
Return to Health Inventory

Observation

One aspect of your laboratory history that stands out is the stability of your recovery. After the dramatic inflammatory spike in October 2021 (ESR 71, CRP 32), every follow-up through July 2022 has remained within the normal reference range.

The month-to-month changes—such as ESR moving from 4 to 13 mm/hr or CRP from 2 to 6 mg/L—are relatively small compared with the changes seen during active disease. This is exactly why preserving the complete chronological record is so valuable: it allows both you and your physicians to distinguish normal biological variation from a true recurrence of systemic inflammation.